CURE’s immunotherapy page features the latest cancer news and updates on immunotherapy Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in immunotherapy.
August 14th 2023
Certain patients with penile squamous cell carcinoma responded to therapy with an immune checkpoint inhibitor, according to recent research.
Billionaire Philanthropist Discusses His Institute's Work to Perfect Cancer Immunotherapy
December 18th 2018Immunotherapy has become a buzzword in the cancer community, but to Sean Parker it’s much more. The 39-year-old billionaire is intensely focused on the promise of immunotherapy, and has become a major force in helping to drive its potential to cure cancers.
New Test May Identify Those Unlikely to Respond to Popular Bladder Cancer Treatment
August 30th 2018While there is currently no definitive way to predict who will respond and who will not, researchers at Brighton and Sussex Medical School in the United Kingdom are working on a blood test that could identify about half of those who may not.
Gender May Play a Role in Immunotherapy Efficacy, Further Studies Are Warranted
June 29th 2018Because little is known about the effect of patients' sex on the efficacy of immune checkpoint inhibitors as cancer treatments, the researchers performed a systematic review and meta-analysis to determine the heterogeneity of immune checkpoint inhibitor efficacy between men and women.
With Checkpoint Inhibitors Here to Stay, Patient Selection Has Become a Science of its Own
June 26th 2018Checkpoint inhibitors — immunotherapy drugs that are improving the treatment landscape for many patients across the spectrum of cancers — are relatively new. The science involved in finding and treating the patients most likely to respond to these drugs — without overlooking any or treating those who won’t benefit — is even newer.
An Important Research Goal: Make Immunotherapy Reliably Effective for More Patients Who Have Cancer
June 26th 2018We've known for over a century about rare patients who experience spontaneous regressions of cancer. We don’t have absolute proof, but, presumably, this occurs because their immune systems are able to rally and fight the disease.
Despite Advances, Education Tools Still Needed for Immunotherapy Treatment
March 5th 2018Recently, the Cancer Support Community (CSC) conducted a survey to better grasp the challenges that patients, caregivers and clinical staff members face regarding immunotherapy. The goal is to ultimately use that information to craft an empowerment program that will improve the patient experience.